Janney Montgomery Scott
RARE icon

Janney Montgomery Scott’s Ultragenyx Pharmaceutical RARE Stock Holding History

Janney Montgomery Scott’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,511
Closed -$286K – 2130
2019
Q2 		$286K Buy
4,511
+515
+13% +$32.8K ﹤0.01% 1718
2019
Q1 		$277K Buy
+3,996
New +$228K ﹤0.01% 1704
2018
Q4 		– Sell
-4,103
Closed -$313K – 2033
2018
Q3 		$313K Buy
+4,103
New +$334K ﹤0.01% 1689

Other funds holding RARE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janney Montgomery Scott's RARE Position: Q3 2019 in Review

Janney Montgomery Scott sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2019, closing a stake of 4,511 shares — an estimated $286K sold.

Janney Montgomery Scott first reported a position in RARE in Q3 2018 and held it in 3 quarters. The position peaked at $313K in Q3 2018. 172 funds tracked by Wall St. Rank hold RARE as of Q3 2019.

  • Janney Montgomery Scott reported no remaining Ultragenyx Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,511 Ultragenyx Pharmaceutical shares in Q3 2019, an estimated $286K.
  • Janney Montgomery Scott first reported a position in Ultragenyx Pharmaceutical in Q3 2018 and held it in 3 quarters.
  • Janney Montgomery Scott's Ultragenyx Pharmaceutical position peaked at $313K in Q3 2018.
  • 172 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2019.

Based on Janney Montgomery Scott's 13F filing for Q3 2019, filed 29 Oct 2019.